CHANGES IN PRIVATE FINANCING OF THE GREEK HEALTH SYSTEM DURING THE ECONOMIC CRISIS

Author(s)

Yfantopoulos J1, Chantzaras A1, Ollandezos M2
1University of Athens, ATHENS, Greece, 2PANHELLENIC ASSOCIATION OF PHARMACEUTICAL INDUSTRY, ATHENS, Greece

OBJECTIVES: Several reforms have been implemented during the recent years to curtail public health spending in Greece. The aim of this study was to explore the impact of the recent reforms and economic crisis on out-of-pocket (OOP) payments

METHODS:

Data for 26.941 households were derived from the Household Budget Surveys for the period 2008-2014. Expenditure data were deflated (2008=100) with the price index and were also equivalised with respect to the economy scale of household consumption. Households were disaggregated into five consumption expenditure quantiles.

RESULTS: Both mean annual equivalised total consumption and OOP payments demonstrated a downward trend during 2008-2014, albeit for consumption the relative change was larger at the end of the period of observation, i.e. -32.3% (from 18402.00 € to 12459.73 €) vs. -21.7% (from 1016.00 € to 795.76 €), respectively; the share of OOP outlays to total consumption increased from 5.5% to 6.4% between 2008 and 2014. In the lowest expenditure quintile, although the share of OOP was reduced from 6.6% to 5.8%, an ascending trend is recorded following 2012. Spending for medical products and inpatient care increased by 25.8% (from 248.60 € to 312.85 €) and 48.45% (from 149.51 € to 222.08 €) respectively, while for outpatient care it decreased by -57.80% (from 617.89 € to 260.84 €). The poorest quintile devoted the chunk of their health spending to medical products across all years, and a 14% rise (from 51% to 66%) is recorded between 2008 and 2014

CONCLUSIONS:

The recent reforms have shifted part of the Greek health system’s financing to health consumers, for pharmaceutical and hospital care in particular. However, the increase in OOP inpatient spending is mainly driven by the higher socioeconomic strata. Promotion of the prescription and dispense of generic medicines may lessen the financial burden related to co-payments for poorer citizens.

Conference/Value in Health Info

2017-11, ISPOR Europe 2017, Glasgow, Scotland

Value in Health, Vol. 20, No. 9 (October 2017)

Code

PRM211

Topic

Methodological & Statistical Research

Topic Subcategory

Confounding, Selection Bias Correction, Causal Inference

Disease

Multiple Diseases

Explore Related HEOR by Topic


Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×